InMed Pharmaceuticals (INM) Capital Expenditures Growth (1y) (2020 - 2024)
Powered by 
Analysis
InMed Pharmaceuticals (INM) Capital Expenditures Growth (1y) (2020 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Corning | 145.18 Bn | 142.67 Bn | 1.63 Bn | 37.01% |
| 2 | Ati | 28.28 Bn | 27.50 Bn | 309.80 Mn | -4.85% |
| 3 | Qnity Electronics | 26.28 Bn | 25.32 Bn | 666.00 Mn | 83.67% |
| 4 | International Flavors & Fragrances | 21.50 Bn | 20.93 Bn | 853.00 Mn | 43.16% |
| 5 | DuPont de Nemours | 17.40 Bn | 15.66 Bn | 639.00 Mn | 52.00% |
| 6 | Avery Dennison | 12.97 Bn | 12.74 Bn | 729.40 Mn | 30.67% |
| 7 | Solstice Advanced Materials | 10.03 Bn | 9.28 Bn | 370.00 Mn | 81.58% |
| 8 | Element Solutions | 8.73 Bn | 8.54 Bn | 334.00 Mn | 57.63% |
| 9 | Eastman Chemical | 7.82 Bn | 7.13 Bn | 560.00 Mn | -33.33% |
| 10 | InMed Pharmaceuticals | 5.30 Mn | 61,528.56 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -100.00% |
| Sep 30, 2023 | 43.38% |
| Jun 30, 2023 | 42.52% |
| Mar 31, 2023 | 3,663.16% |
| Sep 30, 2022 | -102.20% |
| Dec 31, 2021 | -139,350.00% |
| Sep 30, 2021 | 1,684.82% |
| Dec 31, 2020 | -92.91% |
| Sep 30, 2020 | -56.94% |